{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:43:12Z","timestamp":1789598592950,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejim.2014.10.014","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T13:10:40Z","timestamp":1414415440000},"page":"951-955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study"],"prefix":"10.1016","volume":"25","author":[{"given":"Amos","family":"Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eytan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Garty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejim.2014.10.014_bb0005","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1681\/ASN.2005010112","article-title":"Projecting the number of patients with end-stage renal disease in the United States to the year 2015","volume":"16","author":"Gilbertson","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"10.1016\/j.ejim.2014.10.014_bb0010","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","article-title":"Myocardial reperfusion injury: looking beyond primary PCI","volume":"34","author":"Frohlich","year":"2013","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.ejim.2014.10.014_bb0015","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejim.2014.10.014_bb0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","article-title":"Association between serum homocysteine and markers of impaired kidney function in adults in the United States","volume":"66","author":"Francis","year":"2004","journal-title":"Kidney Int"},{"issue":"4\u20135","key":"10.1016\/j.ejim.2014.10.014_bb0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000355722","article-title":"Homocysteine and C-reactive protein as useful surrogate markers for evaluating CKD risk in adults","volume":"37","author":"Chuang","year":"2013","journal-title":"Kidney Blood Press Res"},{"issue":"11","key":"10.1016\/j.ejim.2014.10.014_bb0030","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/01.ATV.17.11.2554","article-title":"Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study","volume":"17","author":"Bostom","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.ejim.2014.10.014_bb0035","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/ndt\/14.12.2903","article-title":"Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients","volume":"14","author":"Jungers","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2014.10.014_bb0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1186\/1471-2458-11-733","article-title":"Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study","volume":"11","author":"Marti","year":"2011","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.ejim.2014.10.014_bb0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.ATV.21.1.74","article-title":"Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn Study","volume":"21","author":"Jager","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.ejim.2014.10.014_bb0050","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2010010085","article-title":"A multi-marker approach to predict incident CKD and microalbuminuria","volume":"21","author":"Fox","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ejim.2014.10.014_bb0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/j.ajkd.2004.05.024","article-title":"Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study","volume":"44","author":"Ninomiya","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.ejim.2014.10.014_bb0060","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ejim.2014.10.014_bb0065","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2014.10.014_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.1016\/j.ejim.2014.10.014_bb0075","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E","article-title":"Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data","volume":"16","author":"Cnaan","year":"1997","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.ejim.2014.10.014_bb0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000045445","article-title":"The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression","volume":"82","author":"Samuelsson","year":"1999","journal-title":"Nephron"},{"issue":"5","key":"10.1016\/j.ejim.2014.10.014_bb0085","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/ajkd.2002.36323","article-title":"Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression","volume":"40","author":"Sarnak","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ejim.2014.10.014_bb0090","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajcn\/77.4.826","article-title":"Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"77","author":"Ganji","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.ejim.2014.10.014_bb0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.ejim.2014.10.014_bb0100","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0735-1097(03)00163-3","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals","volume":"41","author":"Fried","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2014.10.014_bb0105","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1523-1755.2002.kid571.x","article-title":"Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study","volume":"62","author":"Henry","year":"2002","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ejim.2014.10.014_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2004.09.022","article-title":"The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination","volume":"45","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.ejim.2014.10.014_bb0115","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1681\/ASN.2006040402","article-title":"Cardiovascular disease in early stages of chronic kidney disease in a Chinese population","volume":"17","author":"Zhang","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2014.10.014_bb0120","doi-asserted-by":"crossref","DOI":"10.1007\/s40620-014-0077-9","article-title":"A longitudinal assessment of the natural rate of decline in renal function with age","author":"Cohen","year":"2014","journal-title":"J Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2014.10.014_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000328010","article-title":"Aging and physiological changes of the kidneys including changes in glomerular filtration rate","volume":"119","author":"Musso","year":"2011","journal-title":"Nephron Physiol"},{"issue":"5","key":"10.1016\/j.ejim.2014.10.014_bb0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1022130217463","article-title":"Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins","volume":"16","author":"Haynes","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"issue":"11","key":"10.1016\/j.ejim.2014.10.014_bb0135","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.1074\/jbc.M106670200","article-title":"17Beta-estradiol modulates mechanical strain-induced MAPK activation in mesangial cells","volume":"277","author":"Krepinsky","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ejim.2014.10.014_bb0140","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.bjp.0702374","article-title":"Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta","volume":"126","author":"Emsley","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"15","key":"10.1016\/j.ejim.2014.10.014_bb0145","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejim.2014.10.014_bb0150","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/01.CIR.0000027586.64231.1B","article-title":"Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejim.2014.10.014_bb0155","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ki.5002031","article-title":"Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase","volume":"71","author":"Shastry","year":"2007","journal-title":"Kidney Int"},{"issue":"21","key":"10.1016\/j.ejim.2014.10.014_bb0160","doi-asserted-by":"crossref","first-page":"10098","DOI":"10.1016\/S0021-9258(18)61082-8","article-title":"The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells","volume":"262","author":"Heinecke","year":"1987","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.ejim.2014.10.014_bb0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1523-1755.1998.00968.x","article-title":"Ischemic renal diseases: new insights into old entities","volume":"54","author":"Meyrier","year":"1998","journal-title":"Kidney Int"},{"issue":"19","key":"10.1016\/j.ejim.2014.10.014_bb0170","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1053\/euhj.2002.3161","article-title":"Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease","volume":"23","author":"Neal","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2014.10.014_bb0175","first-page":"CD006612","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","volume":"1","author":"Marti-Carvajal","year":"2013","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514002969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514002969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T14:47:49Z","timestamp":1650466069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620514002969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0953620514002969"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2014.10.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2014.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}